Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Club
$299/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Titan Medical Inc. (T:TMD)

Business Focus: Biotechnology & Medical Research

Sector:  Healthcare Industry:  Biotechnology & Medical Research
 
See Regulatory Filings on SEDAR
Company Contact
Address: 170 University Ave
TORONTO ON M5H 3B3
Tel: N/A
Website: https://www.titanmedicalinc.com
IR: See website
Key People
David J. McNally
Chairman of the Board, President, Chief Executive Officer
Monique L. Delorme
Chief Financial Officer
Perry A. Genova
Senior Vice President - Research and Development
Sachin Sankholkar
Vice President of Marketing
Curtis R. Jensen
Vice President - Quality and Regulatory Affairs
Chris Seibert
Vice President - Business Development
Business Overview
Titan Medical Inc. is focused on the development of computer-assisted robotic surgical technologies for application in minimally invasive surgery (MIS) comprising its single-port robotic surgical system. The system under development includes a surgeon-controlled patient cart that includes a three dimension (3D) high definition vision system and multi-articulating instruments for performing MIS procedures and a surgeon workstation that provides the surgeon with an ergonomic interface to the patient cart and a 3D endoscopic view inside the patient's body during MIS procedures. It is developing its SPORT Surgical system as a versatile single incision advanced robotic surgical system that features multi-articulated instruments with single-use replaceable tips. It also features visualization on a flat-screen monitor and a single-arm mobile patient cart while enabling broad applications of a single and multi-quadrant surgeries.
Financial Overview
For the nine months ended 30 September 2020, TitanMedical Inc. revenues increased from $0K to $10M. Net lossdecreased 92% to $3.6M. Revenues reflect an increase indemand for the Company's products and services due tofavorable market conditions. Lower net loss reflectsResearch and development decrease of 95% to $2.4M (expense), Consulting fees decrease of 69% to $318K (expense), Stockbased compensation decrease of 49% to $721K (expense).
Employees: 10 as of Dec 31, 2019
Reporting Currency: U.S. Dollars
Enterprise value: $144.30M as of Sep 30, 2020
Annual revenue (TTM): $12.92M as of Sep 30, 2020
EBITDA (TTM): -$1.61M as of Sep 30, 2020
Net annual income (TTM): -$1.47M as of Sep 30, 2020
Free cash flow (TTM): -$4.21M as of Sep 30, 2020
Net Debt Last Fiscal Year: N/A
Shares outstanding: 82,184,843 as of Nov 16, 2020
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization